Royal London Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-76,035
| Closed | -$14M | – | 680 |
|
|
2021
Q2 | $14M | Buy |
+76,035
| New | +$14M | 0.06% | 271 |
|
|
2021
Q1 | – | Sell |
-79,126
| Closed | -$12.4M | – | 748 |
|
|
2020
Q4 | $12.4M | Sell |
79,126
-1,926
| -2% | -$301K | 0.06% | 250 |
|
|
2020
Q3 | $9.12M | Hold |
81,052
| – | – | 0.06% | 277 |
|
|
2020
Q2 | $9.02M | Sell |
81,052
-4,801
| -6% | -$534K | 0.06% | 268 |
|
|
2020
Q1 | $7.49M | Sell |
85,853
-470
| -0.5% | -$41K | 0.06% | 281 |
|
|
2019
Q4 | $9.27M | Hold |
86,323
| – | – | 0.06% | 279 |
|
|
2019
Q3 | $8.45M | Buy |
+86,323
| New | +$8.45M | 0.06% | 298 |
|
|
2019
Q2 | – | Sell |
-90,158
| Closed | -$12.2M | – | 654 |
|
|
2019
Q1 | $12.2M | Sell |
90,158
-1,237
| -1% | -$167K | 0.1% | 222 |
|
|
2018
Q4 | $8.89M | Buy |
91,395
+6,619
| +8% | +$643K | 0.08% | 258 |
|
|
2018
Q3 | $11.8M | Sell |
84,776
-5,863
| -6% | -$815K | 0.12% | 179 |
|
|
2018
Q2 | $11.3M | Buy |
+90,639
| New | +$11.3M | 0.11% | 195 |
|
|
2016
Q2 | $8.8M | Sell |
75,344
-7,562,666
| -99% | -$883M | 0.14% | 153 |
|
|
2016
Q1 | $55K | Buy |
7,638,010
+7,557,377
| +9,373% | +$54.4K | 0.08% | 284 |
|
|
2015
Q4 | $15.4M | Buy |
80,633
+537
| +0.7% | +$103K | 0.24% | 100 |
|
|
2015
Q3 | $12.5M | Buy |
+80,096
| New | +$12.5M | 0.2% | 117 |
|
|
2014
Q3 | – | Sell |
-46,078
| Closed | -$7.31M | – | 577 |
|
|
2014
Q2 | $7.31M | Sell |
46,078
-200
| -0.4% | -$31.7K | 0.17% | 141 |
|
|
2014
Q1 | $7.46M | Buy |
46,278
+595
| +1% | +$95.9K | 0.17% | 136 |
|
|
2013
Q4 | $6.18M | Buy |
45,683
+575
| +1% | +$77.7K | 0.16% | 151 |
|
|
2013
Q3 | $5.26M | Buy |
45,108
+668
| +2% | +$78K | 0.14% | 171 |
|
|
2013
Q2 | $4.17M | Buy |
+44,440
| New | +$4.17M | 0.12% | 193 |
|